We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+2.17%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$181B
AUM Growth
+$13.3B
Cap. Flow
+$10.5B
Cap. Flow %
5.78%
Top 10 Hldgs %
16.5%
Holding
8,573
New
819
Increased
3,871
Reduced
2,714
Closed
745

Sector Composition

Rank Sector Weight
1 Financials 7.04%
2 Healthcare 5.89%
3 Technology 5.66%
4 Industrials 5.03%
5 Energy 4.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HURA
7551
TuHURA Biosciences
HURA
$136M
0
AIVC
7552
Amplify Bloomberg AI Equal Weight ETF
AIVC
$117M
$1K ﹤0.01%
+46
New +$1.22K
JXG
7553
JX Luxventure
JXG
-1
Closed -$3.23K
WHLM
7554
DELISTED
Wilhelmina International, Inc
WHLM
$1K ﹤0.01%
66
-870
-93% -$8.04K
BYU
7555
DELISTED
BAIYU Holdings, Inc. Common Stock
BYU
$1K ﹤0.01%
+1
New +$1.89K
ISUN
7556
DELISTED
iSun, Inc. Common Stock
ISUN
$1K ﹤0.01%
100
-2,316
-96% -$23.4K
GENE
7557
DELISTED
Genetic Technologies Ltd.
GENE
$1K ﹤0.01%
50
-81
-62% -$2.25K
MDVL
7558
DELISTED
MedAvail Holdings, Inc. Common Stock
MDVL
$1K ﹤0.01%
1
-1
-50% -$898
FRTX
7559
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
$1K ﹤0.01%
2
-4
-67% -$3.25K
TWNK
7560
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
$1K ﹤0.01%
+100
New +$1.21K
CYAD
7561
DELISTED
Celyad Oncology SA American Depositary Shares
CYAD
$1K ﹤0.01%
+64
New +$1.22K
VYNT
7562
DELISTED
Vyant Bio, Inc. Common Stock
VYNT
$1K ﹤0.01%
5
-6
-55% -$1.36K
AMBC.WS
7563
DELISTED
Ambac Financial Group
AMBC.WS
$1K ﹤0.01%
+79
New +$904
PLXP
7564
DELISTED
PLx Pharma Inc. Common Stock
PLXP
$1K ﹤0.01%
63
-14
-18% -$514
RBCN
7565
DELISTED
Rubicon Technology, Inc.
RBCN
$1K ﹤0.01%
140
-20
-13% -$111
DVD
7566
DELISTED
Dover Motorsports
DVD
$1K ﹤0.01%
400
-1,460
-78% -$3.44K
TLND
7567
DELISTED
Talend S.A. American Depositary Shares
TLND
$1K ﹤0.01%
+50
New +$1.17K
DFVS
7568
DELISTED
iPath US Treasury 5-year Bear ETN
DFVS
$1K ﹤0.01%
31
-732
-96% -$22K
SNDE
7569
DELISTED
Sundance Energy Inc. Common Stock
SNDE
$1K ﹤0.01%
+5
New +$707
TAPR
7570
DELISTED
iPath Inverse US Treasury Composite ETN
TAPR
$1K ﹤0.01%
2
-41
-95% -$14.9K
DTUS
7571
DELISTED
iPath US Treasury 2-year Bear ETN
DTUS
$1K ﹤0.01%
+34
New +$1.05K
STPP
7572
DELISTED
iPath US Treasury Steepener ETN
STPP
$1K ﹤0.01%
40
-895
-96% -$29.8K
JPEU
7573
DELISTED
JPMorgan Diversified Return Europe Equity ETF
JPEU
$1K ﹤0.01%
+24
New +$1.18K
BVXVW
7574
DELISTED
BiondVax Pharmaceuticals Ltd.
BVXVW
$1K ﹤0.01%
2,001
-199
-9% -$80
OPGNW
7575
DELISTED
OpGen, Inc. Warrant
OPGNW
$1K ﹤0.01%
14
+2
+17% +$147

Similar funds

UBS Group's Q4 2016 Portfolio in Review

As of Q4 2016, UBS Group held 8,573 positions worth $181B, up 8% from $168B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

UBS Group deployed $10.5B of net new capital in Q4 2016, opening 819 new positions and adding to 3,871 existing holdings. Its largest new stake was Yum China: 1,408,862 shares worth $36.8M.

By sector, the portfolio is most concentrated in Financials at 7% of assets, up from 6.6% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.44B trimmed.

  • UBS Group's largest Q4 2016 buy was Yum China: 1,408,862 shares worth $36.8M.
  • UBS Group added most to Blackrock in Q4 2016, an estimated $356M increase.
  • UBS Group's biggest Q4 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.44B.
  • UBS Group fully exited ITC HOLDINGS CORP in Q4 2016, selling an estimated $56M.
  • UBS Group's ten largest holdings make up 17% of its $181B portfolio in Q4 2016.
  • UBS Group opened 819 new positions and closed 745 in Q4 2016.
  • UBS Group's portfolio value rose 8% quarter-over-quarter to $181B.

Based on UBS Group's 13F filing for Q4 2016, filed 14 Feb 2017.